Replies to post #125900 on Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

What do we call the new dosing protocols? I do not know. Post phase 1? pre 2? Certainly one cannot assume safety if given much more frequently. The MDM2 drugs got into trouble with immune suppression. Every day bone marrow puts out zillions of WBCs, which live days. Giving K 3-5 x a week will certainly mean it might have different side effects than current dosing.

I know nothing about the actual answers to these issues, but would like to. I posed the questions because they are the next obvious big issue with K that I can see